Cargando…

A 2-year evaluation of disease progression by quantitative magnetic resonance imaging in a large primary osteoarthritic patient population

Detalles Bibliográficos
Autores principales:	Raynauld, J-P, Martel-Pelletier, J, Berthiaume, M-J, Beaudoin, G, Labonté, F, Bloch, DA, Choquette, D, Haraoui, B, Altman, RD, Hochberg, M, Beary, J, Cline, G, Meyer, J, Valent, DJ, Pelletier, J-P
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833492/ http://dx.doi.org/10.1186/ar1362

Ejemplares similares

Long term evaluation of disease progression through the quantitative magnetic resonance imaging of symptomatic knee osteoarthritis patients: correlation with clinical symptoms and radiographic changes
por: Raynauld, Jean-Pierre, et al.
Publicado: (2006)

Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study
por: Pelletier, Jean-Pierre, et al.
Publicado: (2007)

Analysis of the precision and sensitivity to change of different approaches to assess cartilage loss by quantitative MRI in a longitudinal multicentre clinical trial in patients with knee osteoarthritis
por: Raynauld, Jean-Pierre, et al.
Publicado: (2008)

Knee meniscal extrusion in a largely non-osteoarthritic cohort: association with greater loss of cartilage volume
por: Ding, Changhai, et al.
Publicado: (2007)

Regulation of collagenase-3 (MMP-13) gene and protein expression in human cartilage: when simple things get complicated
por: Martel-Pelletier, J, et al.
Publicado: (2003)

Fully automated system for the quantification of human osteoarthritic knee joint effusion volume using magnetic resonance imaging
por: Li, Wei, et al.
Publicado: (2010)

Expression and regulation of microsomal prostaglandin E synthase-1 in human osteoarthritic cartilage and chondrocytes
por: Afif, H, et al.
Publicado: (2004)

Total Knee Replacement as a Knee Osteoarthritis Outcome: Predictors Derived from a 4-Year Long-Term Observation following a Randomized Clinical Trial Using Chondroitin Sulfate
por: Raynauld, Jean-Pierre, et al.
Publicado: (2013)

PPARγ ligands inhibit catabolic and inflammatory responses in articular joint cells
por: Fahmi, H, et al.
Publicado: (2003)

Differential gene expression and regulation of the bone morphogenic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts
por: Tardif, G, et al.
Publicado: (2004)

Endothelin-1 in osteoarthritic chondrocytes triggers nitric oxide production and upregulates collagenase production
por: Manacu, CA, et al.
Publicado: (2004)

Galectin-3 in osteoarthritis: from a protective to a destructive role
por: Boileau, C, et al.
Publicado: (2004)

Abnormal collagen type I production in osteoarthritic subchondral bone is associated with a reduced capacity of osteoblasts to mineralize in vitro
por: Aubry, I, et al.
Publicado: (2004)

Altered phosphorylation of Syp may be responsible for abnormal insulin-like growth factor-1 signaling in human osteoarthritic osteoblasts
por: Lajeunesse, D, et al.
Publicado: (2003)

Prostaglandin D2 enhances interleukin -1beta- induced cyclooxygenase-2 expression in osteoarthritic cartilage
por: Zayed, N, et al.
Publicado: (2010)

New strategies for the in vivo regulation of metalloprotease gene expression in osteoarthritis chondrocytes by inflammatory mediators
por: Pelletier, JP, et al.
Publicado: (2003)

Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow
por: Pelletier, Jean-Pierre, et al.
Publicado: (2006)

Issues in structure-modifying osteoarthritis drug development: new insights regarding radiographic clinical trial methods
por: Beary, JF, et al.
Publicado: (2004)

Implication of microRNA-140 in osteoarthritis
por: Martel-Pelletier, Johanne
Publicado: (2012)

Treatment with ephrin B2 positively impacts the abnormal metabolism of human osteoarthritic chondrocytes
por: Kwan Tat, Steeve, et al.
Publicado: (2009)

Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts
por: Massicotte, Frédéric, et al.
Publicado: (2006)

Increased expression of lipocalin-type prostaglandin D(2 )synthase in osteoarthritic cartilage
por: Zayed, Nadia, et al.
Publicado: (2008)

Impact of oral osteoarthritis therapy usage among other risk factors on knee replacement: a nested case-control study using the Osteoarthritis Initiative cohort
por: Dorais, Marc, et al.
Publicado: (2018)

Risk factors associated with the occurrence of total knee arthroplasty in patients with knee osteoarthritis: a nested case–control study
por: Pelletier, Jean-Pierre, et al.
Publicado: (2022)

Risk factors for the long-term incidence and progression of knee osteoarthritis in older adults: role of nonsurgical injury
por: Pelletier, Jean-Pierre, et al.
Publicado: (2023)

Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes
por: Tardif, Ginette, et al.
Publicado: (2009)

The unfolded protein response genes in human osteoarthritic chondrocytes: PERK emerges as a potential therapeutic target
por: Li, Ying-Hua, et al.
Publicado: (2016)

Abnormal osteogenesis in osteoarthritis: gone with the Wnt?
por: Lajeunesse, Daniel, et al.
Publicado: (2012)

High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes
por: García-Arnandis, Isabel, et al.
Publicado: (2010)

The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein
por: Maxis, Kelitha, et al.
Publicado: (2006)

Endothelin-1 in osteoarthritic chondrocytes triggers nitric oxide production and upregulates collagenase production
por: Manacu, Christina Alexandra, et al.
Publicado: (2005)

Exploring determinants predicting response to intra-articular hyaluronic acid treatment in symptomatic knee osteoarthritis: 9-year follow-up data from the Osteoarthritis Initiative
por: Pelletier, Jean-Pierre, et al.
Publicado: (2018)

Intra-articular corticosteroid knee injection induces a reduction in meniscal thickness with no treatment effect on cartilage volume: a case–control study
por: Pelletier, Jean-Pierre, et al.
Publicado: (2020)

Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study
por: Boileau, Christelle, et al.
Publicado: (2007)

Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry
por: Choquette, Denis, et al.
Publicado: (2019)

Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodelling
por: Boileau, Christelle, et al.
Publicado: (2008)

Peroxisome proliferator-activated receptor γ1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1β in articular chondrocytes
por: Afif, Hassan, et al.
Publicado: (2007)

Meniscal extrusion promotes knee osteoarthritis structural progression: protective effect of strontium ranelate treatment in a phase III clinical trial
por: Roubille, Camille, et al.
Publicado: (2015)

Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study
por: Martel-Pelletier, Johanne, et al.
Publicado: (2017)

Cytokine Reduction in the Treatment of Joint Conditions
por: Sipe, J. D., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_dvggcr0di2hvme74rp89r55paf